Sanofi Urges Justices To Deny Amgen's 'Monopoly' Attempt
Sanofi and Regeneron on Friday urged the U.S. Supreme Court to reject Amgen's arguments that it deserves broad patent coverage on cholesterol drugs the rivals both sell, in the one patent case...To view the full article, register now.
Already a subscriber? Click here to view full article